CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS

The occurrence of leprosy has decreased in the world but the perspective of its elimination has been questioned. A proposed control measure is the use of post-exposure chemoprophylaxis (PEP) among contacts, but there are still questions about its operational aspects. In this text we discuss the evidence available in literature, explain some concepts in epidemiology commonly used in the research on this topic, analyze the appropriateness of implementing PEP in the context of Brazil, and answer a set of key questions. We argue some points: (1) the number of contacts that need to receive PEP in order to prevent one additional case of disease is not easy to be generalized from the studies; (2) areas covered by the family health program are the priority settings where PEP could be implemented; (3) there is no need for a second dose; (4) risk for drug resistance seems to be very small; (5) the usefulness of a serological test to identify a higher risk group of individuals among contacts is questionable. Given that, we recommend that, if it is decided to start PEP in Brazil, it should start on a small scale and, as new evidence can be generated in terms of feasibility, sustainability and impact, it could move up a scale, or not, for a wider intervention.

HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT

Chronic infection by hepatitis C virus (HCV) is one of the main risk factors for the development of liver cirrhosis and hepatocellular carcinoma. However, the emergence of hepatocellular carcinoma (HCC) in non-cirrhotic HCV patients, especially after sustained virological response (SVR) is an unusual event. Recently, it has been suggested that HCV genotype 3 may have a particular oncogenic mechanism, but the factors involved in these cases as well as the profile of these patients are still not fully understood. Thus, we present the case of a non-cirrhotic fifty-year-old male with HCV infection, genotype 3a, who developed HCC two years after treatment with pegylated-interferon and ribavirin, with SVR, in Brazil.

Non-clinical isolates bring new findings on enterococcal virulence

Dissertation presented to obtain the PhD degree in Biology

FACTORS RELATED TO ORAL CANDIDIASIS IN ELDERLY USERS AND NON-USERS OF REMOVABLE DENTAL PROSTHESES

This study examined the association between oral candidiasis in elderly users and nonusers of prosthesis and its predisposing factors. To this end, we performed a cross-sectional study where saliva samples from 48 patients were collected they used prosthesis and 43 patients (control group) who did not use. Among the 91 patients, Candida spp were isolated in 40 (83.3%) who used prosthesis and in 23 (53.5%) in the control group. A statistically significant association was determined between the two groups, the isolation of yeasts and dental prosthesis (p < 0.05, OR = 4.3). The most common etiological agent was Candida albicans (37 isolates), with 23 (62.2%) in the denture group and 14 (37.8%) (control group). Among patients who presented clinical manifestations of oral candidiasis (n = 24), 83.3% (n = 20) belonged to the group that wore dentures, while only 16.7% (n = 4) belonged to the control group. Elderly patients with diabetes had 4.4 times higher estimated risk of developing oral candidiasis when compared with individuals without this condition. There was no statistically significant association between being user prostheses and have diabetes with the onset of candidiasis. No statistically significant association was determined between xerostomia, use of prosthesis and oral candidiasis. The use of prosthetics and poor oral hygiene in elderly patients predisposes to the development of oral candidiasis.

O contributo de Julián Marías para uma teoria da filosofia aplicada à questão da felicidade

Tese apresentada para cumprimento dos requisitos necessários à obtenção do grau de doutor em filosofia

Atheroembolic Renal Disease As a Cause of Allograft Primary Non-Function

Atheroembolic renal disease, also referred to as cholesterol crystal embolization, is a rare cause of renal failure, secondary to occlusion of renal arteries, renal arterioles and glomerular capillaries with cholesterol crystals, originating from atheromatous plaques of the aorta and other major arteries. This disease can occur very rarely in kidney allografts in an early or a late clinical form. Renal biopsy seems to be a reliable diagnostic test and cholesterol clefts are the pathognomonic finding. However, the renal biopsy has some limitations as the typical lesion is focal and can be easily missed in a biopsy fragment. The clinical course of these patients varies from complete recovery of the renal function to permanent graft loss. Statins, acetylsalicyclic acid, and corticosteroids have been used to improve the prognosis. We report a case of primary allograft dysfunction caused by an early and massive atheroembolic renal disease. Distinctive histology is presented in several consecutive biopsies. We evaluated all the cases of our Unit and briefly reviewed the literature. Atheroembolic renal disease is a rare cause of allograft primary non -function but may become more prevalent as acceptance of aged donors and recipients for transplantation has become more frequent.

Promoção da saúde mental em espaço urbano

RESUMO: A saúde pública deve estar atenta aos contextos e às mudanças sociais, políticas, económicas, científicas e tecnológicas com que se confrontam constantemente as comunidades, particularmente em situações de grandes transformações como o momento que a União Europeia atravessa. A urbanização é provavelmente a mudança demográfica mais importante das últimas décadas. Tendo importantes repercussões sobre a saúde mental, é importante desenvolver a investigação neste domínio, de forma multidisciplinar e integrando a compreensão dos diferentes determinantes sociais, psicológicos e físicos. As políticas de saúde mental tornaram-se uma parte importante da política social e da sociedade de bem-estar, em particular se considerarmos a urbanização das nossas comunidades. Considerar a saúde mental em espaço urbano é fundamentalmente estudar como um espaço particular pode influenciar a saúde. Baseado nesta reflexão, desenvolveu-se uma investigação participada de base comunitária, com recurso a uma metodologia de estudo de caso. Recorreu-se a dezenas de documentos de referência local, registos em arquivo, à observação direta, à observação participante e à observação in loco do espaço urbano. Foi utilizada uma amostragem em bola de neve, estratificada, para selecionar 697 habitantes de uma cidade da área metropolitana de Lisboa. Estes habitantes foram entrevistados por 42 entrevistadores, previamente formados, assim como foram enviados questionários online dirigidos aos professores (196) e aos Técnicos Superiores de Serviço Social (12) em exercício no espaço urbano em estudo, para a caraterização sociodemográfica e para avaliação de indicadores de saúde, de indicadores relacionados com a saúde e de indicadores estruturais de saúde mental. Os resultados mostraram um espaço urbano promotor de saúde estrutura-se para capacitar os seus cidadãos a se integrarem ativamente no funcionamento da sua comunidade. Foram identificadas algumas caraterísticas como 1) o início do processo de promoção da saúde mental ser o mais precoce possível; 2) a participação comunitária ativa, num sentimento de segurança individual e comunitária, envolvendo estruturas governamentais e não-governamentais; 3) a solidariedade e a inclusão, promovendo o voluntariado e a promoção do suporte social e desenvolvendo a coesão social; 4) o reconhecimento das necessidades expressas pelos habitantes; 5) a identificação de respostas para a conciliação entre vida pessoal, familiar e profissional; 6) as estruturas de acompanhamento dos grupos sociais mais desfavorecidos; 7) as estratégias de combate ao isolamento envolvendo a população sénior e outros grupos minoritários ativamente no processo de reorganização do seu funcionamento social; 8) uma efetiva governança e gestão relacional por parte dos poderes locais, centrando a vida quotidiana da comunidade nas pessoas. A investigação participada de base comunitária constitui um instrumento útil e eficaz no desenho de planos locais de promoção da saúde mental para encontrar respostas ao desafio em saúde pública: a saúde mental e a urbanização.

Evolutive pattern of schistosomiasis and life-span of S. mansoni in patients living in non-endemic area in Brazil

Out of 2484 patients harboring S. mansoni seen in Rio de Janeiro, 1197 had been living permanently out of endemic area frorn one to 30 years, without any possibility of reinfection; 90.1% of these 1197 patients were first seen with, hepato-intestinal schistosomiasis and only 9.9% with hepatosplenic form. 55% of thern still had S. mansoni active infection 6 years or more after they had left the endemic area and 26.5% remained infected for more than 10 years. The patients with intestinal or hepato-intestinal schistosomiasis did not develop the most severe form whether they had been treated or not, and the hepatosplenic patients had a long time to deteriorate.

Non-Progressive Leukoencephalopathy with Bilateral Temporal Cysts

We report two cases of a peculiar leukoencephalopathy with temporal cysts. Both patients have a non-progressive neurological disorder with mental retardation, microcephaly and sensorineural deafness although clinical differences between them may reflect a different aetiology. The metabolic disorders with white matter involvement and the recently described leukoencephalopathies (Van Der Knaap disease, 'vanishing white matter disease') were excluded based on clinical, biologic and imaging findings. Cytomegalovirus infection is a likely possibility in the first case although the magnetic resonance imaging picture is only partially similar to previously reported cases. Our patients are strikingly similar to the patients reported by Deonna et al. and Olivier et al. We discuss the clinical and imaging findings in our patients and the differential diagnosis considering the known disorders of the white matter in childhood.

Cost-Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation in Portugal

INTRODUCTION AND OBJECTIVES:Recently, three novel non-vitamin K antagonist oral anticoagulants received approval for reimbursement in Portugal for patients with non-valvular atrial fibrillation (AF). It is therefore important to evaluate the relative cost-effectiveness of these new oral anticoagulants in Portuguese AF patients. METHODS: A Markov model was used to analyze disease progression over a lifetime horizon. Relative efficacy data for stroke (ischemic and hemorrhagic), bleeding (intracranial, other major bleeding and clinically relevant non-major bleeding), myocardial infarction and treatment discontinuation were obtained by pairwise indirect comparisons between apixaban, dabigatran and rivaroxaban using warfarin as a common comparator. Data on resource use were obtained from the database of diagnosis-related groups and an expert panel. Model outputs included life years gained, quality-adjusted life years (QALYs), direct healthcare costs and incremental cost-effectiveness ratios (ICERs). RESULTS:Apixaban provided the most life years gained and QALYs. The ICERs of apixaban compared to warfarin and dabigatran were €5529/QALY and €9163/QALY, respectively. Apixaban was dominant over rivaroxaban (greater health gains and lower costs). The results were robust over a wide range of inputs in sensitivity analyses. Apixaban had a 70% probability of being cost-effective (at a threshold of €20 000/QALY) compared to all the other therapeutic options. CONCLUSIONS:Apixaban is a cost-effective alternative to warfarin and dabigatran and is dominant over rivaroxaban in AF patients from the perspective of the Portuguese national healthcare system. These conclusions are based on indirect comparisons, but despite this limitation, the information is useful for healthcare decision-makers.

Effects of lethal and non-lethal malaria on the mononuclear phagocyte system

The effects ofone non-lethal species ofmalarialparasite, Plasmodium yoelii, and one lethal species, P. berghei, on the mononuclear phagocyte system (MPS) of BALB/c mice were studied. P. yoelii caused a greater and more sustained expansion and activation of the MPS, and the two major populations of spleen phagocytic cells-red pulp and marginal zone macrophages - exhibited a greater increase in numbers in this infection. During the course of P. berghei mataria, the spleen was progressively occupied by haematopoietic tissue and, at the terminal stage of infection, an extensive depletion of lymphocytes and macrophages was apparent. The possibility was suggested that the outcome of mataria may be inftuenced by the particular way the parasite interacts with the MPS.

How to sell successfully a perfume in the non-selective market?

A Work Project, presented as part of the requirements for the Award of a Masters Degree in Management from the NOVA – School of Business and Economics

Adesão terapêutica em doentes submetidos a transplante hepático e renal

RESUMO - Introdução - A não adesão à terapêutica nos doentes transplantados foi identificada em diversos estudos e constitui um fator preditivo de morbilidade e mortalidade. Como em Portugal não existe um conhecimento aprofundado sobre os comportamentos de não adesão nos doentes transplantados, este estudo tem como objetivo a avaliação da adesão terapêutica nos doentes submetidos a transplante hepático e renal e a identificação de fatores associados à não adesão. Metodologia - Foi elaborado e aplicado um questionário a uma amostra de doentes com mais de 18 anos submetidos a transplante renal ou hepático há mais de seis meses. Foi analisada a associação entre o comportamento de não adesão e fatores relacionados com o doente, condição, terapêutica e acesso aos serviços de saúde. Resultados - Dos 75 inquiridos, 60% eram doentes transplantados de fígado e 40% transplantados renais, com uma média de 48 anos e maioritariamente do sexo masculino (65,3%). Entre os inquiridos, verificou-se que 44% admitiu ter tido um comportamento de não adesão aos medicamentos prescritos. Os doentes que reportaram comportamento de não adesão tinham uma média de idades de 44 anos, possuíam como escolaridade o ensino secundário ou curso profissional, trabalhavam ou estudavam, tomavam menos de oito comprimidos por dia e tinham sido transplantados há mais de 5 anos. Adicionalmente, verificou-se que a dieta (28,8%), o exercício físico (33,3%) e o deixar de fumar (10,7%) são as indicações dadas pelos profissionais de saúde que os doentes referiram ter mais dificuldade em cumprir. Conclusão - Com este estudo esperamos ter contribuído para aumentar o conhecimento sobre a adesão à terapêutica nos doentes transplantados, o qual deve ser aprofundado para permitir o desenvolvimento de estratégias efetivas de melhoria da adesão aos planos terapêuticos.

Identity dynamics in non-profit organizations: Ideological and methodological identity orientations

A Work Project, presented as part of the requirements for the Award of a Masters Degree in Management from the NOVA – School of Business and Economics

How differently do our non-large companies listed on the Portuguese Stock Exchange perform?

A Work Project, presented as part of the requirements for the Award of a Masters Degree in Economics from the NOVA – School of Business and Economics